ECSP951559A - 5-LIPOXIGENASE INHIBITORS - Google Patents

5-LIPOXIGENASE INHIBITORS

Info

Publication number
ECSP951559A
ECSP951559A ECSP951559A ECSP951559A EC SP951559 A ECSP951559 A EC SP951559A EC SP951559 A ECSP951559 A EC SP951559A EC SP951559 A ECSP951559 A EC SP951559A
Authority
EC
Ecuador
Prior art keywords
compounds
refers
lipoxigenase inhibitors
lipoxigenase
inhibitors
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Yoshiyuki Okumura
Rodney William Stevens
Takashi Mano
Kazunari Nako
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP951559 priority Critical patent/ECSP951559A/en
Publication of ECSP951559A publication Critical patent/ECSP951559A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se refiere a nuevos compuestos. Los compuestos de ésta invención inhiben la acción de la enzima lipoxigenasa y son útiles en el tratamiento o alivio de enfermedades inflamatorias, alergia y enfermedades cardiovasculares en mamíferos. Se refiere también a composiciones farmacéuticas que comprenden dichos compuestos.It refers to new compounds. The compounds of this invention inhibit the action of the enzyme lipoxygenase and are useful in the treatment or relief of inflammatory diseases, allergies and cardiovascular diseases in mammals. It also refers to pharmaceutical compositions comprising said compounds.

ECSP951559 1995-10-17 1995-10-17 5-LIPOXIGENASE INHIBITORS ECSP951559A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP951559 ECSP951559A (en) 1995-10-17 1995-10-17 5-LIPOXIGENASE INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP951559 ECSP951559A (en) 1995-10-17 1995-10-17 5-LIPOXIGENASE INHIBITORS

Publications (1)

Publication Number Publication Date
ECSP951559A true ECSP951559A (en) 1997-04-04

Family

ID=42042201

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP951559 ECSP951559A (en) 1995-10-17 1995-10-17 5-LIPOXIGENASE INHIBITORS

Country Status (1)

Country Link
EC (1) ECSP951559A (en)

Similar Documents

Publication Publication Date Title
NO20032254D0 (en) Compounds for inhibiting expression of VACM-I
GT199700074A (en) DERIVATIVES OF 2- (2-OXO-ETILIDEN) -IMIDAZOLIDIN-4-ONA
BG101841A (en) CELLULAR ADHESION INHIBITORS
BG104247A (en) PRODUCTION OF RESOURCINES
TR200200160T2 (en) Imidazoles and triazoles as anti-inflammatory agents
ES2174465T3 (en) TRIAZOL COMPOUNDS AND ITS USE AS DOPAMINE-D.
DE69612003D1 (en) SUBSTITUTED BENZOLACTATE COMPOUNDS AS SUBSTANCE P-ANTAGONISTS
TR199902545T2 (en) Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular diseases
ATE193304T1 (en) HUMAN NEUTROPHIL ELASTASIS INHIBITORS
PT695758E (en) AMIDES AND ESTERS OF PENTAPEPTIDOS HUMAN CANCER INHIBITORS
MX9800348A (en) CELL ADHESION INHIBITORS.
HN2001000244A (en) SPIROPIRIMIDIN INHIBITORS - 2, 4, 6 - TRIONA METALOPROTEINASAS.
ES2189207T3 (en) INHIBITORS OF REVERSED HYDROXAMATES OF MARY METALOPROTEINASES.
MA27509A1 (en) SUSTAINED RELEASE FORMULATIONS CONTAINING LAMOTRIGIN
NO934218L (en) Inhibitors of cathepsin g and elastase to prevent connective tissue degradation
ES2170143T3 (en) COMPOSITIONS THAT INCLUDE HALOFANTRINE IN A SPECIAL FORM.
ATE516027T1 (en) ORAZAMID OROTAT TO PREVENT LIVER DAMAGE
ES2064119T3 (en) NEW DERIVATIVES OF AMINOBENZOSULTAM AS LIPOXIGENASE INHIBITORS.
DE60329326D1 (en) TACE INHIBITORS
DE69625230D1 (en) thrombin inhibitors
ES2142490T3 (en) CYCLOPEPTOLIDS.
ATE305517T1 (en) NEUROTRYPSIN
NO20005548L (en) Mykobakterieinhibitorer
ATE305785T1 (en) CD45 INHIBITORS
ATE317384T1 (en) LTA4 HYDROLASE INHIBITORS